Correlation Between Imunon and Abcellera BiologicsInc
Can any of the company-specific risk be diversified away by investing in both Imunon and Abcellera BiologicsInc at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Imunon and Abcellera BiologicsInc into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Imunon Inc and Abcellera BiologicsInc, you can compare the effects of market volatilities on Imunon and Abcellera BiologicsInc and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Imunon with a short position of Abcellera BiologicsInc. Check out your portfolio center. Please also check ongoing floating volatility patterns of Imunon and Abcellera BiologicsInc.
Diversification Opportunities for Imunon and Abcellera BiologicsInc
-0.69 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Imunon and Abcellera is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding Imunon Inc and Abcellera BiologicsInc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Abcellera BiologicsInc and Imunon is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Imunon Inc are associated (or correlated) with Abcellera BiologicsInc. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Abcellera BiologicsInc has no effect on the direction of Imunon i.e., Imunon and Abcellera BiologicsInc go up and down completely randomly.
Pair Corralation between Imunon and Abcellera BiologicsInc
Given the investment horizon of 90 days Imunon Inc is expected to generate 3.45 times more return on investment than Abcellera BiologicsInc. However, Imunon is 3.45 times more volatile than Abcellera BiologicsInc. It trades about 0.19 of its potential returns per unit of risk. Abcellera BiologicsInc is currently generating about -0.18 per unit of risk. If you would invest 57.00 in Imunon Inc on February 19, 2024 and sell it today you would earn a total of 83.00 from holding Imunon Inc or generate 145.61% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Imunon Inc vs. Abcellera BiologicsInc
Performance |
Timeline |
Imunon Inc |
Abcellera BiologicsInc |
Imunon and Abcellera BiologicsInc Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Imunon and Abcellera BiologicsInc
The main advantage of trading using opposite Imunon and Abcellera BiologicsInc positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Imunon position performs unexpectedly, Abcellera BiologicsInc can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abcellera BiologicsInc will offset losses from the drop in Abcellera BiologicsInc's long position.The idea behind Imunon Inc and Abcellera BiologicsInc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Abcellera BiologicsInc vs. Pfizer Inc | Abcellera BiologicsInc vs. Nayax | Abcellera BiologicsInc vs. HP Inc | Abcellera BiologicsInc vs. GCM Grosvenor |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |